Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Islatravir

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck-Gilead long-acting oral combo suppresses HIV for 48 weeks
    Merck-Gilead long-acting oral combo suppresses HIV for 48 weeks

    22 Oct 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/merck-gilead-long-acting-oral-combo-suppresses-hiv-48-weeks-setting-stage-pivotal-program

    FIERCE BIOTECH
    22 Oct 2024
    Share Share
    Merck-Gilead's weekly HIV combo maintains viral suppression
    Merck-Gilead's weekly HIV combo maintains viral suppression

    07 Mar 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/merck-gileads-weekly-hiv-combo-maintains-viral-suppression-its-early-days-primary-endpoint

    FIERCE BIOTECH
    07 Mar 2024
    Share Share
    Merck Opens Enrollment in PIII with Islatravir in Combination with Doravirine
    Merck Opens Enrollment in PIII with Islatravir in Combination with Doravirine

    22 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230222005448/en

    BUSINESSWIRE
    22 Feb 2023
    Share Share
    Merck’s HIV pipeline shifts as islatravir PrEP program is discontinued
    Merck’s HIV pipeline shifts as islatravir PrEP program is discontinued

    29 Sep 2022

    // Adam Zamecnik PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/mercks-hiv-pipeline-shifts-as-prep-program-discontinues/

    Adam Zamecnik PHARMACEUTICAL-TECHNOLOGY
    29 Sep 2022
    Share Share
    Merck to start studying lower dose of HIV drug after FDA hold
    Merck to start studying lower dose of HIV drug after FDA hold

    21 Sep 2022

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/merck-start-new-study-low-dose-hiv-drug-after-fdas-hold-2022-09-20/

    REUTERS
    21 Sep 2022
    Share Share
    FDA pauses several trials of Merck’s investigational HIV drug
    FDA pauses several trials of Merck’s investigational HIV drug

    16 Dec 2021

    // PHARMAFILE

    http://www.pharmafile.com/news/600180/fda-pauses-several-trials-merck-s-investigational-hiv-drug

    PHARMAFILE
    16 Dec 2021
    Share Share